Swine Flu News and Research

RSS
Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.
NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Sinovac Beijing receives GMP certificate for its proprietary vaccines

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

UCLA researchers predict hotspots for future outbreaks of influenza virus

UCLA researchers predict hotspots for future outbreaks of influenza virus

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Nursing home patients with pneumonia may need viral screening

Nursing home patients with pneumonia may need viral screening

Influenza vaccine linked to narcolepsy in children in England

Influenza vaccine linked to narcolepsy in children in England

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

New molecular compounds can kill the influenza virus

New molecular compounds can kill the influenza virus

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows

1 in 5 people infected with swine flu during first year of epidemic, WHO-led study shows

New research sets out alternative approach to pandemic preparedness

New research sets out alternative approach to pandemic preparedness

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides to advance influenza drug candidate with completed $5M funding

Researchers report seroprevalence of three avian flu virus strains in pigs in southern China

Researchers report seroprevalence of three avian flu virus strains in pigs in southern China

Georgia State researcher discover new process to make one-time flu vaccine

Georgia State researcher discover new process to make one-time flu vaccine

mRNA vaccines offer protection against influenza A virus infections in various animal models

mRNA vaccines offer protection against influenza A virus infections in various animal models

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

Myths about the influenza vaccine

Myths about the influenza vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.